ThinkSabio

$CGTX

$0.87▲ +2.4% YTD

3 SEC 13D/G filings tracked · Last updated Oct 13, 2026

Filing History
News
CGTX ▲ +2.4% - Cognition Therapeutics, Inc.
CP $0.87▲ +2.4%Oct 13, 2026 · ThinkSabio Blog

$CGTX - Cognition Therapeutics Announces Issuance of Composition of Matter Patent, Extending Protection for Zervimesine (CT1812) Through 2045…

News
CGTX ▲ +2.1% - Cognition Therapeutics, Inc.
CP $0.96▲ +2.1%Sep 29, 2026 · ThinkSabio Blog

$CGTX - Cognition Therapeutics Schedules a Type C Meeting with FDA to Align on Endpoints for Phase 3 Trial of Zervimesine (CT1812) in DLB…

News
CGTX ▲ +1.0% - Cognition Therapeutics, Inc.
CP $1.04▲ +1.0%Sep 8, 2026 · ThinkSabio Blog

$CGTX - Cognition Therapeutics to Present at H.C. Wainwright Global Investment Conference…